Download A New Vision for Radiation Therapy

A New Vision for Radiation Therapy
The MRIdian™ system gives physicians more control over the delivery
of their radiation therapy prescriptions.
With other radiotherapy technologies, imaging can only take place before
or after the treatment; while the beam is on, clinicians cannot see exactly
where the therapy target is located inside a patient’s body. Even with
precise treatment plans, the motion of internal soft tissues can cause a
tumor and nearby organs to be in different positions when the treatment
actually occurs.
The MRIdian system was designed to solve this problem. Using a patented
combination of magnetic resonance imaging (MRI) and radiation therapy
delivery technologies, the MRIdian system provides continuous softtissue imaging during treatment. Clinicians can see the target, monitor the
radiation dose, and adapt to changes in the patient’s anatomy—all in real
time.
If the patient moves during treatment—simply
taking a breath or swallowing can be enough
to shift internal organs—clinicians must be
able to refine the target so the tumor will get
an optimized dose.
The ViewRay solution | With the MRIdian system, clinicians can see the tumor, refine the
target, and adapt to changes in the patient’s anatomy—while the treatment is in progress.
The MRIdian system assures that the treatment is delivered only when the target is safely
within parameters set by the physician—parameters based on the exact position of the
tumor at the moment of treatment.
Real-time MRI gives clinicians a
clear view of the patient’s anatomy
throughout the treatment.
Applications
Management
Nearly two-thirds of all cancer patients receive radiation therapy during their illness. The
MRIdian system, with MRI capabilities, is intended to provide stereotactic radiosurgery
and precision radiation therapy for lesions, tumors, and conditions anywhere in the body
where radiation treatment is indicated.
Chris A. Raanes
President and CEO
David Chandler
Chief Financial Officer
With extensive experience in the medical
device field, Chris Raanes has held
executive positions at companies such as
Accuray and PerkinElmer Optoelectronics.
As executive vice president and chief
operating officer at Accuray, Raanes was
instrumental in transforming the company
from a start-up niche player into the
number three vendor in the radiation
therapy industry. He holds an MSEE from
the Massachusetts Institute of Technology.
Veteran CFO David Chandler has nearly
three decades of experience in finance,
strategic planning, mergers and acquisitions, investor relations, and accounting.
Working with an array of businesses,
Chandler has raised more than $100
million in private debt and equity capital,
and $80 million in private M&A.
James F. Dempsey, PhD
Chief Scientific Officer
Garth Nobis brings to ViewRay a proven
track record in quality assurance and
regulatory affairs. He has achieved a wide
range of U.S. and international regulatory approvals, in addition to establishing
robust quality systems for medical device
companies such as Beckton Dickenson,
Guidant, and several start-ups. Nobis holds
an MBA from the University of Dayton.
MRIdian’s design specifically enables the treatment of organs that are likely to move
significantly during therapy, as lung tumors move when patients breathe. The ability to
see soft tissue and adjust to its motion in real time can help assure clinicians that they
are delivering the intended dose of radiation and avoiding normal tissues and critical
structures, such as the spinal cord. In addition to lung cancer, ViewRay’s technology may
be beneficial with tumors in head and neck, prostate, breast, bladder, and other types
of cancer where tumor and organ motion can affect treatments.
MRI is the clinically preferred method of imaging soft tissue. MRI technology (above left), can give
clinicians a clearer view of the patient’s internal organs, such as the prostate, without delivering the
extra ionizing radiation of computed tomography, or CT (above right).
Company founder and inventor of the
ViewRay technology, James Dempsey
guides the scientific and technical aspects
of the MRIdian system’s development.
Dempsey holds a PhD in nuclear chemistry
from Washington University. He is a
board-certified medical physicist and
former associate professor of radiation
oncology at the University of Florida.
Prabhakar Tripuraneni, MD, FACR,
FASTRO
About ViewRay
Chief Medical Officer
A privately held medical device company, ViewRay Incorporated holds the exclusive
worldwide license for its patented combination of MRI and radiation therapy technologies.
Early adopters of the MRIdian system include the Siteman Cancer Center at Barnes-Jewish
Hospital and Washington University School of Medicine in St. Louis, Missouri; the
University of Wisconsin Carbone Cancer Center; and the University of California, Los
Angeles, Health System—Jonsson Comprehensive Cancer Center.
Currently the head of radiation oncology at Scripps Green Hospital in La
Jolla, California, Prabhakar Tripuraneni is
a pioneer in coronary vascular brachytherapy. A graduate of Guntur Medical
College in South India, he is the former
president of ASTRO, the American Society
for Therapeutic Radiology and Oncology.
To learn more about ViewRay products and partnerships, contact your local ViewRay
representative.
ViewRay Incorporated
2 Thermo Fisher Way
Oakwood Village, OH 44146
+1 440 703 3210
www.viewray.com
© 2014 ViewRay Incorporated. All rights reserved. ViewRay
and MRIdian are trademarks of ViewRay Incorporated.
The names of other companies and products mentioned
herein are used for identification purposes only and may
be trademarks or registered trademarks of their respective owners. Rx ONLY L-0002 Rev. G 08/2014
Garth M. Nobis
Vice President of Regulatory Affairs
and Quality Assurance
Michael Brandt
Senior Vice President of Sales
A veteran of the radiation therapy and
medical imaging industries, Michael
Brandt leads ViewRay’s worldwide sales
and marketing programs. Prior to joining
ViewRay, Brandt served as general manager
of Accuray’s Americas and Europe, Middle
East, India, and Africa (EMEIA) divisions,
and held a series of international management positions at Philips Medical Systems.
Stephen J. Strunk
Vice President of Manufacturing
An operations expert, Stephen Strunk
specializes in the development and
manufacturing of complex technologies.
With more than two decades of experience in the medical device and high-tech
industries, Strunk has held executive
positions at companies such as Accuray,
PerkinElmer, and Teledyne Dalsa.